Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 3
1(25.0%)
4Total
N/A(3)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07523958Not ApplicableRecruiting

Paraffin Oil for Preventing Tourniquet-Related Skin Lesions in Upper Extremity Surgery

Role: collaborator

NCT06154850Not ApplicableCompleted

Effects of Virtual Reality on Brain Hemodynamic Activity in Chronic Pain

Role: collaborator

NCT04729517Phase 3Completed

Efficacy and Safety Study of AI201901 in Allergic Rhinitis Patients

Role: collaborator

NCT04240470Not ApplicableCompleted

Endovascular Stroke Treatment Only (ESTO) Trial

Role: collaborator

All 4 trials loaded